Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals
NASDAQ | Common Stock
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company.
The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery.
The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014.
Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
As of October 10, 2023, Zynerba Pharmaceuticals, Inc. operates as a subsidiary of Harmony Biosciences Holdings, Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 23 | -0.21 Increased by +12.50% | -0.20 Decreased by -5.00% |
| May 15, 23 | -0.21 Increased by 0.00% | -0.19 Decreased by -10.53% |
| Mar 28, 23 | -0.18 Increased by +18.18% | -0.18 |
| Nov 14, 22 | -0.20 Increased by +23.08% | -0.22 Increased by +9.09% |
| Aug 10, 22 | -0.24 Increased by +4.00% | -0.23 Decreased by -4.35% |
| May 16, 22 | -0.21 Decreased by -5.00% | -0.23 Increased by +8.70% |
| Mar 1, 22 | -0.22 Increased by +33.33% | -0.26 Increased by +15.38% |
| Nov 15, 21 | -0.26 Increased by +16.13% | -0.25 Decreased by -4.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 0.00 Decreased by N/A% | -10.78 M Decreased by -2.27% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -9.76 M Decreased by -20.79% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -7.62 M Increased by +13.59% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -8.86 M Increased by +16.28% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -10.54 M Decreased by -5.90% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -8.08 M Decreased by -1.45% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -8.82 M Increased by +8.35% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 21 | 0.00 Decreased by N/A% | -10.58 M Decreased by -16.95% | Decreased by N/A% Decreased by N/A% |